Literature DB >> 26166607

Impact of Metformin on Male Reproduction.

Carolina Ferreira, Mário Sousa, Ana Rabaça, Pedro F Oliveira, Marco G Alves, Rosália Sá1.   

Abstract

Male infertility has been increasing over the last decades being nowadays a pressing health problem. Diabetes mellitus (DM) can contribute directly or indirectly to male infertility due to an abnormal spermatogenesis, which results in a decreased sperm quality. Type 2 Diabetes mellitus (T2DM) is responsible for the vast majority of DM cases, being frequently treated with oral antidiabetic drugs. Metformin is the most cost-effective therapy for the treatment of T2DM. This biguanide is an oral insulin-sensitizing agent capable of increasing insulin sensitivity and decreasing plasma fasting insulin levels. The main metabolic action of this drug occurs in the liver. However, it has been shown that metformin acts on a variety of organs including the male reproductive system. With the rising numbers of diabetic individuals among younger populations, there is an increase in the consumption of metformin in individuals of this age group. As a result, it is important to discuss the role of metformin in male fertility. This review presents the most recent data available from studies on the effects of metformin on male reproductive system. Together with the discussion of these effects, their significance to male fertility is also debated.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26166607     DOI: 10.2174/1381612821666150710150041

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  6 in total

1.  Transcriptomic landscape profiling of metformin-treated healthy mice: Implication for potential hypertension risk when prophylactically used.

Authors:  Yuhong Meng; Rui Xiang; Han Yan; Yiran Zhou; Yuntao Hu; Jichun Yang; Yuan Zhou; Qinghua Cui
Journal:  J Cell Mol Med       Date:  2020-06-11       Impact factor: 5.310

2.  Melatonin attenuates detrimental effects of diabetes on the niche of mouse spermatogonial stem cells by maintaining Leydig cells.

Authors:  Zhaoyu Du; Shuanshuan Xu; Shuxian Hu; Hong Yang; Zhe Zhou; Kuldip Sidhu; Yiliang Miao; Zhonghua Liu; Wei Shen; Russel J Reiter; Jinlian Hua; Sha Peng
Journal:  Cell Death Dis       Date:  2018-09-20       Impact factor: 8.469

3.  Inhibition of Microtubule Affinity Regulating Kinase 4 by Metformin: Exploring the Neuroprotective Potential of Antidiabetic Drug through Spectroscopic and Computational Approaches.

Authors:  Ghulam Md Ashraf; Debarati DasGupta; Mohammad Zubair Alam; Saleh S Baeesa; Badrah S Alghamdi; Firoz Anwar; Thamer M A Alqurashi; Sharaf E Sharaf; Waleed Al Abdulmonem; Mohammed A Alyousef; Fahad A Alhumaydhi; Anas Shamsi
Journal:  Molecules       Date:  2022-07-21       Impact factor: 4.927

4.  Clomiphene citrate effect in obese men with low serum testosterone treated with metformin due to dysmetabolic disorders: A randomized, double-blind, placebo-controlled study.

Authors:  Carla Pelusi; Vito Angelo Giagulli; Margherita Baccini; Flaminia Fanelli; Marco Mezzullo; Alessia Fazzini; Nicola Bianchi; Matteo Domenico Carbone; Giovanni De Pergola; Marianna Mastroroberto; Antonio Maria Morselli Labate; Renato Pasquali
Journal:  PLoS One       Date:  2017-09-08       Impact factor: 3.240

5.  Editorial: Metformin: Beyond Diabetes.

Authors:  Frédéric Bost; Graham Rena; Benoit Viollet
Journal:  Front Endocrinol (Lausanne)       Date:  2019-12-06       Impact factor: 5.555

Review 6.  The Effect of Metformin on Male Reproductive Function and Prostate: An Updated Review.

Authors:  Chin-Hsiao Tseng
Journal:  World J Mens Health       Date:  2021-03-09       Impact factor: 5.400

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.